Interpretation of Chinese guidelines for diagnosis and treatment of Guillain-Barré syndrome 2019
10.3760/cma.j.issn.1006-7876.2019.11.001
- VernacularTitle: 中国吉兰-巴雷综合征诊治指南2019解读
- Author:
Mingsheng LIU
1
;
Liying CUI
2
Author Information
1. Department of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China
2. Department of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China; Center for Neuroscience, Chinese Academy of Medical Sciences, Beijing 100730, China
- Publication Type:Editorial
- Keywords:
Guillain-Barré syndrome;
Practice guideline;
Electrophysiology;
Therapeutics
- From:
Chinese Journal of Neurology
2019;52(11):873-876
- CountryChina
- Language:Chinese
-
Abstract:
The neuroelectrophysiological test and immunotherapy for Guillain-Barré syndrome were further discussed according to Chinese guidelines for diagnosis and treatment of Guillain-Barré syndrome 2019. Neuroelectrophysiological test should be performed and interpreted according to clinical background in the diagnosis of Guillain-Barré syndrome. Intravenous immunoglobulin therapy should be adopted individually according to the severity and course of the disease and other factors.
